ProShare Advisors’s Revolution Medicines RVMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $256K | Sell |
6,955
-38,298
| -85% | -$1.41M | ﹤0.01% | 1560 |
|
|
2025
Q1 | $1.6M | Sell |
45,253
-9,849
| -18% | -$348K | ﹤0.01% | 703 |
|
|
2024
Q4 | $2.41M | Buy |
55,102
+16,438
| +43% | +$719K | 0.01% | 664 |
|
|
2024
Q3 | $1.75M | Buy |
38,664
+9,796
| +34% | +$444K | ﹤0.01% | 690 |
|
|
2024
Q2 | $1.12M | Sell |
28,868
-7,737
| -21% | -$300K | ﹤0.01% | 734 |
|
|
2024
Q1 | $1.18M | Buy |
36,605
+2,331
| +7% | +$75.1K | ﹤0.01% | 755 |
|
|
2023
Q4 | $983K | Buy |
34,274
+13,962
| +69% | +$400K | ﹤0.01% | 760 |
|
|
2023
Q3 | $562K | Buy |
20,312
+243
| +1% | +$6.73K | ﹤0.01% | 872 |
|
|
2023
Q2 | $537K | Buy |
20,069
+3,558
| +22% | +$95.2K | ﹤0.01% | 911 |
|
|
2023
Q1 | $358K | Sell |
16,511
-533
| -3% | -$11.5K | ﹤0.01% | 1095 |
|
|
2022
Q4 | $406K | Buy |
17,044
+1,458
| +9% | +$34.7K | ﹤0.01% | 1069 |
|
|
2022
Q3 | $307K | Buy |
15,586
+2,723
| +21% | +$53.6K | ﹤0.01% | 1139 |
|
|
2022
Q2 | $251K | Sell |
12,863
-5,954
| -32% | -$116K | ﹤0.01% | 1321 |
|
|
2022
Q1 | $480K | Sell |
18,817
-4,535
| -19% | -$116K | ﹤0.01% | 1301 |
|
|
2021
Q4 | $588K | Buy |
23,352
+23
| +0.1% | +$579 | ﹤0.01% | 1343 |
|
|
2021
Q3 | $642K | Sell |
23,329
-5,274
| -18% | -$145K | ﹤0.01% | 1067 |
|
|
2021
Q2 | $908K | Buy |
28,603
+7,224
| +34% | +$229K | ﹤0.01% | 1096 |
|
|
2021
Q1 | $981K | Buy |
21,379
+2,589
| +14% | +$119K | ﹤0.01% | 997 |
|
|
2020
Q4 | $744K | Buy |
+18,790
| New | +$744K | ﹤0.01% | 1019 |
|